Turnstone Biologics Corp. Stock Price

NasdaqCM:TSBX Community·US$8.2m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

TSBX Share Price Performance

US$0.35

-0.11 (-23.33%)

US$0.35

-0.11 (-23.33%)

US$0.35

Fri, 16 Jan 26

Share Pricen/a

TSBX Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Adequate balance sheet slight.

4 Risks

0 Rewards

View Full Analysis

Turnstone Biologics Corp. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -2.04
: 0%
: 0%
: 0%

View Full Analysis

About TSBX

Founded: 2014
Employees: 8
CEO: Sammy Farah
WebsiteView website: turnstonebio.com

Turnstone Biologics Corp. operates as a biotechnology company. The company was founded in 2014 and is headquartered in San Diego, California.

Recent TSBX News & Updates

Recent updates

No updates

Turnstone Biologics Corp. Competitors

Turnstone Biologics Corp. Stock Price

TSBX Share Price Performance

TSBX Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

Turnstone Biologics Corp. Key Details

About TSBX

Recent TSBX News & Updates

Turnstone Biologics Corp.(NasdaqCM:TSBX) dropped from NASDAQ Composite Index

XOMA Royalty Corporation (NasdaqGM:XOMA) completed the acquisition of Turnstone Biologics Corp. (NasdaqCM:TSBX).

XOMA Royalty Corporation (NasdaqGM:XOMA) agreed to acquire Turnstone Biologics Corp.

Recent updates

Turnstone Biologics Corp. Competitors

Veritas Farms

Hoth Therapeutics

Cocrystal Pharma

Zenith Capital